Keel Point’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $687K | Buy |
6,198
+259
| +4% | +$28.7K | 0.05% | 233 |
|
|
2025
Q1 | $665K | Buy |
5,939
+1,578
| +36% | +$177K | 0.05% | 196 |
|
|
2024
Q4 | $403K | Sell |
4,361
-404
| -8% | -$37.3K | 0.03% | 270 |
|
|
2024
Q3 | $399K | Buy |
4,765
+1,368
| +40% | +$115K | 0.03% | 279 |
|
|
2024
Q2 | $251K | Buy |
+3,397
| New | +$251K | 0.02% | 358 |
|
|
2020
Q2 | – | Sell |
-3,338
| Closed | -$250K | – | 188 |
|
|
2020
Q1 | $250K | Buy |
+3,338
| New | +$250K | 0.03% | 151 |
|
|
2017
Q3 | – | Sell |
-3,123
| Closed | -$221K | – | 166 |
|
|
2017
Q2 | $221K | Buy |
3,123
+12
| +0.4% | +$849 | 0.04% | 145 |
|
|
2017
Q1 | $211K | Buy |
3,111
+11
| +0.4% | +$746 | 0.04% | 150 |
|
|
2016
Q4 | $222K | Buy |
+3,100
| New | +$222K | 0.05% | 143 |
|